Search Results 1221-1230 of 16595 for monoclonal antibody

  1. Immune Cells that Go Rogue and Prompt Pancreatic Cancer - Mayo Clinic News Network

    ... antibody to standard-of-care chemotherapy. “Our hope is that the antibody will neutralize the IL-13 in patients, making pancreatic tumors more susceptible ...

  2. BCL2 Inhibitor Venetoclax With Daratumumab-Lenalidomide-Dexamethasone Or Venetoclax-Rd for Newly Diagnosed Multiple Myeloma - Mayo Clinic

    * ≥ 200 mg of monoclonal protein in the urine on 24 hour electrophoresis * ... * Presence of positive hepatitis C antibody ... antibody test are not required to ...

  3. A Study to Evaluate the Safety And Effectiveness of Using Eculizumab in Patients with Relapsing Neuromyelitis Optica - Mayo Clinic

    Complement activation after binding of an IgG autoantibody ... monoclonal IgG that neutralises the complement protein C5--in neuromyelitis optica spectrum ...

  4. Publications - Christopher J. Klein, M.D. - Mayo Clinic

    LGI1 antibody encephalitis: acute treatment comparisons and outcome. ... Autoimmune/Paraneoplastic Encephalitis Antibody ... monoclonal protein-skin changes and ...

  5. Elevate CLL R/R: Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia - Mayo Clinic

    Monoclonal B-cells (either kappa or lambda light chain restricted) that are ... Subjects with hepatitis B core antibody positive who are surface antigen negative ...

  6. Mayo-Adimune Collaborative and Programmatic Approach to Tolerization Therapy

    The purpose of this study is to target two autoimmune neurological conditions that we consider proof of principal T cell- and antibody ... antibody titer greater ...

  7. A Study Evaluating the Safety and Effectiveness of JCAR017 to Treat Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) - Mayo Clinic

    Anti-CD20 monoclonal antibodies within 7 days prior to leukapheresis 11. Venetoclax within 4 days prior to leukapheresis 12. Idelalisib or duvelisib within ...

  8. Publications - Kah Whye Peng, Ph.D. - Mayo Clinic

    ... antibody responses to Omicron and historical variants, independent of measles seropositivity. mBio. 2024 Feb 14; 15 (2):e0292823 Epub 2024 Jan 09. View ...

  9. Panobinostat and Everolimus in Treating Patients with Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma - Mayo Clinic

    Serum monoclonal protein ≥ 1.0 g/dL; ≥ 200 mg of monoclonal protein in the ... Monoclonal bone marrow plasmacytosis ≥ 30% (evaluable disease) at time of ...

  10. CTX131 in Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

    Concurrent systemic treatment with an anticancer biologic (e.g., monoclonal antibody) within 30 days prior to CTX131 infusion or with a non-biological ...